Hidemaru Yamaguchi
Stock Analyst at Citi
(2.40)
# 3,029
Out of 5,023 analysts
65
Total ratings
55.8%
Success rate
1.7%
Average return
Main Sectors:
Stocks Rated by Hidemaru Yamaguchi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4503 Astellas Pharma Inc. | Reiterated: Hold | ¥2,400 → ¥2,470 | ¥2,245 | +10.02% | 4 | Aug 7, 2026 | |
| TYO: 4587 PeptiDream Inc. | Reiterated: Hold | ¥1,600 → ¥1,100 | ¥1,076 | +2.23% | 3 | Jul 22, 2026 | |
| TYO: 4592 SanBio Company Limited | Upgraded: Buy | ¥1,800 | ¥941 | +91.29% | 1 | Jul 16, 2026 | |
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Reiterated: Sell | ¥1,260 → ¥1,500 | ¥1,614 | -7.03% | 5 | May 25, 2026 | |
| TYO: 2503 Kirin Holdings Company, Limited | Downgraded: Hold | ¥2,800 | ¥2,805 | -0.18% | 1 | Apr 3, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Sell | ¥3,800 → ¥2,000 | ¥2,230 | -10.31% | 2 | Mar 10, 2026 | |
| TYO: 2413 M3, Inc. | Reiterated: Buy | ¥2,600 → ¥2,800 | ¥1,753 | +59.73% | 6 | Feb 9, 2026 | |
| TYO: 4552 JCR Pharmaceuticals Co., Ltd. | Reiterated: Hold | ¥600 → ¥670 | ¥484 | +38.43% | 4 | Feb 5, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Reiterated: Buy | ¥5,800 → ¥4,900 | ¥2,709 | +80.88% | 6 | Feb 5, 2026 | |
| TYO: 4565 Nxera Pharma Co., Ltd. | Reiterated: Buy | ¥1,100 → ¥1,400 | ¥1,220 | +14.75% | 5 | Nov 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥5,900 → ¥6,200 | ¥4,700 | n/a | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,800 → ¥3,900 | ¥2,244 | n/a | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,200 → ¥3,500 | ¥3,293 | n/a | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥1,750 | ¥2,290 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥10,400 → ¥10,500 | ¥11,320 | n/a | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥5,100 → ¥4,600 | ¥3,378 | n/a | 3 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥2,600 | ¥1,646 | n/a | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥4,200 → ¥3,500 | ¥3,495 | n/a | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥960 | ¥1,602 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥2,410 | ¥2,920 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥2,600 | ¥2,030 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥12,000 | ¥6,032 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,100 → ¥2,800 | ¥2,786 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥3,300 | ¥1,819 | n/a | 1 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $35.61 | n/a | 1 | Mar 29, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $25.40 | n/a | 1 | Nov 18, 2009 |
Astellas Pharma Inc.
Aug 7, 2026
Reiterated: Hold
Price Target: ¥2,400 → ¥2,470
Current: ¥2,245
Upside: +10.02%
PeptiDream Inc.
Jul 22, 2026
Reiterated: Hold
Price Target: ¥1,600 → ¥1,100
Current: ¥1,076
Upside: +2.23%
SanBio Company Limited
Jul 16, 2026
Upgraded: Buy
Price Target: ¥1,800
Current: ¥941
Upside: +91.29%
Sumitomo Pharma Co., Ltd.
May 25, 2026
Reiterated: Sell
Price Target: ¥1,260 → ¥1,500
Current: ¥1,614
Upside: -7.03%
Kirin Holdings Company, Limited
Apr 3, 2026
Downgraded: Hold
Price Target: ¥2,800
Current: ¥2,805
Upside: -0.18%
Kyowa Kirin Co., Ltd.
Mar 10, 2026
Downgraded: Sell
Price Target: ¥3,800 → ¥2,000
Current: ¥2,230
Upside: -10.31%
M3, Inc.
Feb 9, 2026
Reiterated: Buy
Price Target: ¥2,600 → ¥2,800
Current: ¥1,753
Upside: +59.73%
JCR Pharmaceuticals Co., Ltd.
Feb 5, 2026
Reiterated: Hold
Price Target: ¥600 → ¥670
Current: ¥484
Upside: +38.43%
Daiichi Sankyo Company, Limited
Feb 5, 2026
Reiterated: Buy
Price Target: ¥5,800 → ¥4,900
Current: ¥2,709
Upside: +80.88%
Nxera Pharma Co., Ltd.
Nov 28, 2025
Reiterated: Buy
Price Target: ¥1,100 → ¥1,400
Current: ¥1,220
Upside: +14.75%
Sep 12, 2025
Reiterated: Buy
Price Target: ¥5,900 → ¥6,200
Current: ¥4,700
Upside: n/a
Aug 29, 2025
Reiterated: Buy
Price Target: ¥3,800 → ¥3,900
Current: ¥2,244
Upside: n/a
Aug 29, 2025
Reiterated: Buy
Price Target: ¥3,200 → ¥3,500
Current: ¥3,293
Upside: n/a
Aug 28, 2025
Reiterated: Hold
Price Target: ¥1,750
Current: ¥2,290
Upside: n/a
Aug 27, 2025
Reiterated: Buy
Price Target: ¥10,400 → ¥10,500
Current: ¥11,320
Upside: n/a
Aug 26, 2025
Reiterated: Buy
Price Target: ¥5,100 → ¥4,600
Current: ¥3,378
Upside: n/a
Aug 22, 2025
Reiterated: Buy
Price Target: ¥2,600
Current: ¥1,646
Upside: n/a
Aug 22, 2025
Reiterated: Buy
Price Target: ¥4,200 → ¥3,500
Current: ¥3,495
Upside: n/a
Jun 26, 2025
Reiterated: Hold
Price Target: ¥960
Current: ¥1,602
Upside: n/a
Jun 26, 2025
Reiterated: Hold
Price Target: ¥2,410
Current: ¥2,920
Upside: n/a
Jun 24, 2025
Downgraded: Hold
Price Target: ¥2,600
Current: ¥2,030
Upside: n/a
May 27, 2025
Reiterated: Buy
Price Target: ¥12,000
Current: ¥6,032
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: ¥3,100 → ¥2,800
Current: ¥2,786
Upside: n/a
Nov 26, 2024
Reiterated: Hold
Price Target: ¥3,300
Current: ¥1,819
Upside: n/a
Mar 29, 2010
Upgraded: Buy
Price Target: n/a
Current: $35.61
Upside: n/a
Nov 18, 2009
Upgraded: Hold
Price Target: n/a
Current: $25.40
Upside: n/a